University Vascular Associates

Recent papers from University Vascular Associates

1. Frameworks to identify research gaps, frame research needs, and derive research priorities from evidence syntheses:a scoping review2026
2. Local immune networks promote respiratory IgA responses after mucosal vaccination 2260370The Journal of Immunology · 2026
3. Preliminary Analysis of the Relationship between Health Insurance Status and Spontaneous Intracerebral Hemorrhage Characteristics (P2-5.002)Neurology · 2026
4. The Paradoxical Experience of Support: Receiving and ProvidingGestalt Review · 2026
5. Arnold Beisser, Smoking, and the Paradoxical Theory of ChangeGestalt Review · 2026
6. 477: Bromocriptine for the Reduction of Central Fever in Patients With Severe Brain InjuryCritical Care Medicine · 2026
7. Deep Red Blood Cell Proteome Defines the Band 3 N-Terminus Interactome as a Regulator of Hypoxic Adaptation via BLVRB-Dependent S -Nitroso Transfer2025
8. Reconsidering the Relationship of Disability and Deservingness of Care with the Advent of Enhanced Warfighters: A Capability Approach to Veterans’ Health CareAJOB Neuroscience · 2025
9. Mixed Gambles in Product Recalls: How CEO Stock Options Drive Impression Management TacticsJournal of Management · 2025
10. Operationalization of Cochrane’s Risk of Bias 2 Tool (RoB 2) in the Context of Psychotherapy Trials2025
11. Benzotriazole (BTA): A Review of the Current Research into ToxicityJournal of the American Institute for Conservation · 2025
12. N-acetylcysteine to reduce kidney and liver injury associated with drug-resistant tuberculosis treatment2025
13. Nightmare FuelM/C Journal · 2024
14. Microglia modulate cerebral blood flow and neurovascular coupling through ectonucleotidase CD392024
15. Regulatory Aspects of Artificial Intelligence and Machine LearningModern Pathology · 2024
16. Is mind-mindedness in mothers, fathers and children related to child adaptive and maladaptive emotion regulation?2024
17. Assessing and Addressing the Determinants of Appalachian Population Health2024
18. Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on EnzalutamideClinical Cancer Research · 2024
19. Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasisClinical and Translational Science · 2023
20. A randomized, double‐blind, placebo‐controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosisEuropean Journal of Neurology · 2023